» Articles » PMID: 25932301

Deep Brain Stimulation of the Subthalamic and Pedunculopontine Nucleus in a Patient with Parkinson's Disease

Overview
Date 2015 May 2
PMID 25932301
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Deep brain stimulation (DBS) of the pedunculopontine nucleus (PPN) is a novel therapy developed to treat Parkinson's disease. We report a patient who underwent bilateral DBS of the PPN and subthalamic nucleus (STN). He suffered from freezing of gait (FOG), bradykinesia, rigidity and mild tremors. The patient underwent bilateral DBS of the PPN and STN. We compared the benefits of PPN-DBS and STN-DBS using motor and gait subscores. The PPN-DBS provided modest improvements in the gait disorder and freezing episodes, while the STN-DBS failed to improve the dominant problems. This special case suggests that PPN-DBS may have a unique role in ameliorating the locomotor symptoms and has the potential to provide improvement in FOG.

Citing Articles

Anticipatory Postural Adjustments and Compensatory Postural Responses to Multidirectional Perturbations-Effects of Medication and Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease.

Hess T, Oehlwein C, Milani T Brain Sci. 2023; 13(3).

PMID: 36979264 PMC: 10046463. DOI: 10.3390/brainsci13030454.


Exercise Therapies for Parkinson's Disease: A Systematic Review and Meta-Analysis.

Choi H, Cho K, Jin C, Lee J, Kim T, Jung W Parkinsons Dis. 2020; 2020:2565320.

PMID: 32963753 PMC: 7495242. DOI: 10.1155/2020/2565320.


Vitexin protects dopaminergic neurons in MPTP-induced Parkinson's disease through PI3K/Akt signaling pathway.

Hu M, Li F, Wang W Drug Des Devel Ther. 2018; 12:565-573.

PMID: 29588573 PMC: 5859909. DOI: 10.2147/DDDT.S156920.


Parkinson's disease as a system-level disorder.

Caligiore D, Helmich R, Hallett M, Moustafa A, Timmermann L, Toni I NPJ Parkinsons Dis. 2017; 2:16025.

PMID: 28725705 PMC: 5516580. DOI: 10.1038/npjparkd.2016.25.


Dopamine and the Brainstem Locomotor Networks: From Lamprey to Human.

Ryczko D, Dubuc R Front Neurosci. 2017; 11:295.

PMID: 28603482 PMC: 5445171. DOI: 10.3389/fnins.2017.00295.


References
1.
Stefani A, Lozano A, Peppe A, Stanzione P, Galati S, Tropepi D . Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain. 2007; 130(Pt 6):1596-607. DOI: 10.1093/brain/awl346. View

2.
Rodriguez-Oroz M, Obeso J, Lang A, Houeto J, Pollak P, Rehncrona S . Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain. 2005; 128(Pt 10):2240-9. DOI: 10.1093/brain/awh571. View

3.
Jenkinson N, Nandi D, Miall R, Stein J, Aziz T . Pedunculopontine nucleus stimulation improves akinesia in a Parkinsonian monkey. Neuroreport. 2004; 15(17):2621-4. DOI: 10.1097/00001756-200412030-00012. View

4.
Follett K, Weaver F, Stern M, Hur K, Harris C, Luo P . Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med. 2010; 362(22):2077-91. DOI: 10.1056/NEJMoa0907083. View

5.
Classen J, Schnitzler A . What does the pedunculopontine nucleus do?. Neurology. 2010; 75(11):944-5. DOI: 10.1212/WNL.0b013e3181f25b73. View